Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Sees Large Growth in Short Interest

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 600 shares, a growth of 20.0% from the November 30th total of 500 shares. Based on an average daily volume of 500 shares, the short-interest ratio is currently 1.2 days.

Mosaic ImmunoEngineering Stock Performance

Shares of Mosaic ImmunoEngineering stock remained flat at $0.70 during trading hours on Friday. The stock had a trading volume of 324 shares, compared to its average volume of 898. The company has a market capitalization of $5.08 million, a price-to-earnings ratio of -4.67 and a beta of 0.15. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13. The firm has a 50-day moving average of $0.90 and a two-hundred day moving average of $0.84.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.